Clinical trial
Low Intensity Focused Ultrasound Modulation of Thalamic Nuclei for Central Neuropathic Pain: A Double- Blind Controlled Study.
NCT06978764 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low Intensity Focused Ultrasound Modulation of Thalamic Nuclei for Central Neuropathic Pain: A Double- Blind Controlled Study.
- Lead sponsor
- University of Sao Paulo
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- November 19, 2024
- Completion date
- April 25, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
central neuropathic pain